Drug-Diagnostics Co-Development in Oncology
The idea of combining drugs and diagnostics in oncology is not new. When the selective estrogen receptor modulator tamoxifen was developed in the 1970's for the treatment of breast cancer a positive correlation between receptor status and treatment outcome was found. As a result of this researc...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book Chapter |
| Published: |
Frontiers Media SA
2014
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Get FullteksDOAB: description of the publication
3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |